Another baby formula shipment from Europe to arrive in the U.S. on Wednesday

Another baby formula shipment from Europe to arrive in the U.S. on Wednesday


Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, May 10, 2022.

Kaylee Greenlee Beal | Reuters

FedEx Express has secured a government contract to bring another shipment of infant formula to the U.S. on Wednesday, NBC News reported.

The Express plane will fly Nestlé baby formula from Ramstein Air Base in Germany to Dulles International Airport near Washington, D.C. From there, the formula will be transported to a Nestlé facility in Pennsylvania. It’s unclear how much formula the plane will carry.

The move is meant to address a critical shortage of baby formula in the United States after top formula maker Abbott Laboratories closed a manufacturing plant following reports of bacterial infections in four infants.

Abbott said it would take about two weeks to reopen the plant and up to eight weeks for products to hit the shelves nationwide. That’s left a wide gap for scores of parents across the nation.

In an effort to ease the burden, the Food and Drug Administration is increasing baby formula imports from other countries. Dubbed “Operation Fly Formula,” the first shipment, carrying 78,000 pounds of specialty infant formula, arrived Sunday.

President Joe Biden has also invoked the Defense Production Act to increase baby formula manufacturing. His administration is seeking to stock shelves with 1.5 million containers of Nestle specialty infant formula.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More